NHS launches campaign as a third still don't attend cervical cancer screenings
From the age of 25, cervical cancer screenings are advised – but one in three aren’t attending them. Despite calls for the starting age to be lowered along with changes in what specifically is tested for to make them even…
Read MoreUK could be on the brink of another viral outbreak – it can cause ‘disability and death’
Measles: UNICEF warns Coronavirus could bring resurgence We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You…
Read MoreCancer: The cholesterol-lowering medication that could slash men’s prostate cancer risk
Nanoknife: Expert discusses new prostate cancer treatment We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You…
Read MoreStudy explores omicron-reactive T- and B- cell responses in COVID-19 vaccine recipients
The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant (B.1.1.529) is a major concern, even among vaccinated individuals. Study: Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients. Image Credit: Imilian/Shutterstock This…
Read MoreStealth version of Omicron variant no cause for alarm, experts say
(HealthDay)—The so-called “stealth” variant of Omicron isn’t likely to cause another devastating wave of COVID-19, experts say. The new version of the variant, called BA.2, doesn’t appear to cause more severe disease and vaccines are just as effective against it…
Read MoreEmotional Eating May Override GLP-1 Agonist Weight Loss Effect
Emotional eating behavior may partly explain why some people don’t lose weight with a new type of treatment for obesity, glucagon-like peptide-1 (GLP-1) receptor agonists, new research suggests. Used to treat type 2 diabetes and obesity, GLP-1 agonists reduce blood…
Read MoreDevelopment of QCC-targeting therapeutic agents may lead to new cancer treatments
Announcing a new review article publication for Acta Materia Medica journal. Quiescent cancer cells (QCCs) reversibly reside in G0 phase, thus allowing them to survive chemotherapy and radiotherapy, which generally target proliferating cells. Surviving QCCs may re-proliferate, and consequently result…
Read MoreProcess-scale Chromatography Bed Supports
Porvair Sciences high performance, precision manufactured Vyon® porous plastics are perfect support materials for chromatographic resins used in the isolation and purification steps of pharmaceutical drug and vaccine production. Image credit: Porvair Sciences Manufactured from virgin-grade polymers, compliant with EU…
Read MoreACS/ASCO Websites Are Cross-Posting Patient Info
In a new collaboration, the American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) are cross-posting cancer information for patients on their websites, the groups announced on February 1. “We’ve made it easier for your patients to…
Read MoreMillions of Brits are happy to live with Covid and continue wearing masks in public
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info…
Read More